Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy. [electronic resource]
Producer: 20121218Description: 2720-33 p. digitalISSN:- 1460-2385
- Angiotensin II Type 1 Receptor Blockers -- antagonists & inhibitors
- Angiotensin Receptor Antagonists -- therapeutic use
- Animals
- Blotting, Western
- Collagen Type I -- genetics
- Collagen Type III -- genetics
- Drug Therapy, Combination
- Fibronectins -- genetics
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Kidney Diseases -- etiology
- Losartan -- therapeutic use
- Male
- NF-kappa B -- genetics
- Nephrectomy -- adverse effects
- Pyridines -- therapeutic use
- RNA, Messenger -- genetics
- Rats
- Rats, Sprague-Dawley
- Real-Time Polymerase Chain Reaction
- Reverse Transcriptase Polymerase Chain Reaction
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.